Abstract:The objective of this study was to investigate the absorption behavior of chikusetsusaponin IVa (CHS-IVa) in the rat intestine using single-pass intestinal perfusion (SPIP) and to classify CHS-IVa into the biopharmaceutics classification system (BCS). The equilibrium solubility of CHS-IVa was determined by the shaker method. The absorption mechanism of CHS-IVa in the intestine was studied by comparing the Peff of different concentrations of CHS-IVa. The intestinal site dependence of CHS-IVa absorption was studied by comparing the Peff of the same concentration of CHS-IVa in different intestinal segments. The relationship between CHS-IVa and intestinal efflux protein was studied by perfusion with an efflux protein inhibitor. The permeability of CHS-IVa was investigated by comparing the Peff of CHS-IVa and the reported value. The solubility of CHS-IVa over the pH range 1.0-7.5 was 14.4 ± 0.29 to 16.9 ± 0.34 mg/ml. The Peff of CHS-IVa in the duodenum was 1.76 × 10-3 to 2.00 × 10-3 cm/min. The Peff of CHS-IVa in the jejunum was 1.26 × 10-3 to 1.39 × 10-3 cm/min. The Peff of CHS-IVa in the ileum was 1.25 × 10-3 to 1.31 × 10-3 cm/min. The Peff of CHS-IVa in the colon was 1.02 × 10-3 to 1.08 × 10-3 cm/min. There was no statistical difference of the Peff in the four segments at different CHS-IVa concentrations. The Peff of CHS-IVa (0.07, 0.7 and 7.0 mg/ml) were all notably smaller than the reported Peff (3.00 × 10-3 cm/min) in the jejunum. The Peff of CHS-IVa was not influenced by verapamil (P-gp inhibitor), indomethacin (MRP inhibitor) and pantoprazole (BCRP inhibitor). CHS-IVa was classified as high solubility, low permeability and BCS III. The main absorptive tracts were the upper intestinal tracts and the rank order of intestinal permeability was duodenum > jejunum ≈ ileum > colon. The transport mechanism of CHS-IVa in all intestinal segments might be primarily passive transport. CHS-IVa was not a substrate of P-gp, MRP and BCRP.

Study on the Absorption Kinetics of Benazepril Hydrochloride

Study on Absorption Kinetics of Phenolic Alkaloids from Menispermum Dauricum in Rats' Intestines

Absorption Barriers in the Rat Intestinal Mucosa: 2. Application of Physiologically Based Mathematical Models to Quantify Mechanisms of Drug Permeation and Metabolism

Study on Correlation Between in vitro Release and in vivo Absorption of Captopril Delayed-onset, Sustained Release Tablet

Study on Correlation Between {\sl in Vitro} Release and {\sl in Vivo} Absorption of Captopril Delayed--onset, Sustained Release Tablet

Absorption Kinetics of Naproxen Sodium in Rats

Study on the Rat Intestinal Absorption Kinetics of Duloxetine Hydrochloride in Vitro

Study on the Intestinal Absorption Kinetics of Aipian in Rats

In situ Intestinal Absorption Kinetics of Carvedilol Nanosuspensions in Rats

Intestinal Absorption Kinetics of Rhamnosylvitexin in Rats

Absorption kinetics of breviscapine in intestine of rats in situ

Studies on absorption kinetics of paeoniflorin microemulsion in rat's intestines

[Absorption Kinetics of Atractylenolide I in Intestines of Rats].

Effects of structural modifications on the intestinal permeability of angiotensin II receptor antagonists and the correlation of in vitro, in situ, and in vivo absorption

Study on the transdermal penetration mechanism of ibuprofen nanoemulsions

Studies on Absorption of Paeoniflorin in Rat Small Intestines by HPLC-MS

Studies on Intestinal Absorption Characteristics of Tetrahydropalmatine in Rats

Biopharmaceutics classification and intestinal absorption of chikusetsusaponin IVa

Intestinal Absorption of Cefixime in Rats

Human small intestinal and colonic tissue mounted in the Ussing chamber as a tool for characterizing the intestinal absorption of drugs

Influence of pH Environment on Nasal Absorption of Meptazinol Hydrochloride